# Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model (2020)

## Brief Summary


## Data

Private data from:

- [The Health Improvement Network (THIN)](https://www.the-health-improvement-network.com/),
- [IQVIA Canada EMR Primary Care Data](https://www.iqvia.com/solutions/real-world-evidence/real-world-data-and-insights), and
- [Morris Kahn Maccabi Health Data Science Institut](https://www.ksminnovation.com/about/)

## Preprocessing and data decisions

Variables considered:

- `age`
- `gender`
- `BMI`
- `HbA1c`
- `glucose`

## Target

Diabetes defined as:

- Glucose ≥126 mg/dL within 2 years or;
- HbA1c ≥ 6.5% within 2 years or;
- Glucose ≥200 mg/dL in a single measurement or;
- Diagnosed Diabetes or;
- Initiating any glucose lowering agent other than metformin (which is often prescribed to pre-diabetic individuals) without prior fulfilment of the diabetes glycaemic criteria.
